Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies

Novo Nordisk said Thursday it's still struggling to meet demand for its wildly popular weight-loss medications as its third-quarter profit jumped.

Related Keywords

United States ,Denmark ,America ,Danish , ,Novo Nordisk ,North America ,Eli Lilly ,Article Normal ,Pharmaceuticals ,Machinery ,Agricultural Machinery ,Healthcare Life Sciences ,Industrial Goods ,Financial Performance ,Earnings ,Sales Figures ,Corporate Industrial News ,Political General News ,Physical Mental Fitness ,Health ,Living Lifestyle ,Weight Management ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Novo Nordiskas Adr ,Nvo ,Novo Nordiska S ,Dk Novo B ,Corporate ,Industrial News ,Political ,General News ,Physical ,Mental Fitness ,Living ,Lifestyle ,Healthcare ,Life Sciences ,